DISCLOSURE OF DERIVATIVE FINANCIAL STATEMENTS OF THE BRAZILIAN COMPANIES IN THE HEALTH MARKET
Abstract
Derivative minimize the risks of companies operating with foreign currencies and future sales. The use of these financial instruments is increasing through many Brazilian companies that don´t evidence for the lack of effective regulation. The publicly traded companies must show in the notes the risks involved in the operations, the market value and the criteria and assumptions to determine this value of financial instruments and the policies of operation and control of operations. Therefore, the goals of this study is to investigate how is the disclosure of derivatives in the financial statements. It has been done a descriptive research, analyzing the five Brazilian companies in the healthcare sector of the BM&FBovespa, from 2008 to 2012. Was observed that only two companies showed the use of derivatives in all the years analyzed and presented correctly the data sensitivity analysis and risk evaluation. The types of derivatives used by surveyed companies were: forward exchange, currency swap and call option agreement. All companies use derivatives only for hedging purposes. It is noteworthy also that none of the companies surveyed presents quantitative information of its derivatives in the notes in the form of the table contained in Instruction CVM 475 (2008b). From the data analysis, it can be inferred that firms do not fully follow applicable accounting standards, not performing sensitivity analyzes in all years, assessment and measurement of risks in all cases, and not showing adequate and sufficiently derivatives in the notes.
Keywords: Derivatives. Disclosure. Branch Health BM&FBovespa. Corporate Accounting. International Accounting Standards.
Downloads
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Authors who publish in this magazine agree with the following terms:
Authors keep the copyrights and concede the right of its first publication to the magazine. The work piece must be simultaneously licensed on the Creative Commons Attribution Licence which allows the paper sharing, and preserves both the author identity and the right of first publication to this magazine.
Authors are authorized to assume additional contracts separately, to not-exclusively distribution of the paper version published in this magazine (e.g.: publish in institutional repository or as a book chapter), with the author identity recognition and its first publication in this magazine.
Authors are permitted and stimulated to publish and distribute their papers online (e.g.: in institutional repository or on their personal webpage), considering it can generate productive alterations, as well as increase the impact and the quotations of the published paper.
Creative Commons - Atribuição-NãoComercial-SemDerivações 4.0 Internacional.